Molecular markers in ductal carcinoma in situ of the breast.
Dale Porter, Kornélia Polyák(Dana-Farber Cancer Institute), Jeffrey R. Marks(Duke Medical Center), Jaana Lahti‐Domenici(Dana-Farber Cancer Institute), Edward Gabrielson(Johns Hopkins University), Gregory J. Riggins(Unknown), Rebecca Gelman(Dana-Farber Cancer Institute), Young Kyung Bae(Johns Hopkins University), Aparna Keshaviah(Dana-Farber Cancer Institute), Robert L. Strausberg(Ludwig Cancer Research), Amiel G. Cooper(Harvard University Press), Stuart J. Schnitt(Brigham and Women's Hospital), Pedram Argani(Johns Hopkins University), Andrea L. Richardson(Brigham and Women's Hospital)
PubMed
March 1, 2003
Cited by 261
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k